Ameriprise Financial Inc Ptc Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

  • $415 Billion
  • Q3 2025

A detailed history of Ameriprise Financial Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 10,630 shares of PTCT stock, worth $800,439. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,630
Previous 10,630 -0.0%
Holding current value
$800,439
Previous $519,000 25.63%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$36.19 - $52.13 $272,619 - $392,695
-7,533 Reduced 41.47%
10,630 $519,000
Q1 2025

May 14, 2025
SELL
$41.81 - $57.17 $1.04 Million - $1.42 Million
-24,771 Reduced 57.7%
18,163 $925,000
Q4 2024

Feb 14, 2025
SELL
$34.99 - $52.07 $914,148 - $1.36 Million
-26,126 Reduced 37.83%
42,934 $1.94 Million
Q3 2024

Nov 14, 2024
SELL
$30.39 - $37.66 $297,578 - $368,766
-9,792 Reduced 12.42%
69,060 $2.56 Million
Q2 2024

Aug 14, 2024
BUY
$24.69 - $40.12 $128,412 - $208,664
5,201 Added 7.06%
78,852 $2.41 Million
Q1 2024

May 15, 2024
BUY
$24.15 - $31.95 $3,694 - $4,888
153 Added 0.21%
73,651 $2.14 Million
Q4 2023

Feb 14, 2024
SELL
$18.07 - $29.37 $10.2 Million - $16.5 Million
-562,280 Reduced 88.44%
73,498 $2.03 Million
Q3 2023

Nov 14, 2023
BUY
$22.41 - $41.99 $5.26 Million - $9.85 Million
234,592 Added 58.47%
635,778 $14.2 Million
Q2 2023

Aug 14, 2023
BUY
$40.4 - $59.1 $12.9 Million - $18.9 Million
320,131 Added 394.96%
401,186 $16.3 Million
Q1 2023

May 15, 2023
BUY
$38.16 - $48.86 $1.11 Million - $1.42 Million
29,111 Added 56.04%
81,055 $3.93 Million
Q4 2022

Feb 14, 2023
BUY
$33.53 - $54.79 $1.16 Million - $1.89 Million
34,476 Added 197.37%
51,944 $1.98 Million
Q3 2022

Nov 14, 2022
SELL
$41.85 - $53.85 $13,433 - $17,285
-321 Reduced 1.8%
17,468 $876,000
Q2 2022

Aug 15, 2022
SELL
$25.6 - $45.23 $5,862 - $10,357
-229 Reduced 1.27%
17,789 $713,000
Q1 2022

May 16, 2022
BUY
$33.33 - $44.6 $600,539 - $803,602
18,018 New
18,018 $672,000
Q2 2021

Aug 16, 2021
SELL
$37.95 - $49.37 $448,075 - $582,911
-11,807 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$46.8 - $68.92 $739,674 - $1.09 Million
-15,805 Reduced 57.24%
11,807 $559,000
Q4 2020

Feb 12, 2021
SELL
$47.96 - $67.64 $663,190 - $935,325
-13,828 Reduced 33.37%
27,612 $1.69 Million
Q3 2020

Nov 16, 2020
SELL
$45.41 - $57.07 $751,535 - $944,508
-16,550 Reduced 28.54%
41,440 $1.94 Million
Q2 2020

Aug 14, 2020
BUY
$42.56 - $54.98 $261,531 - $337,852
6,145 Added 11.85%
57,990 $2.94 Million
Q1 2020

May 15, 2020
BUY
$32.37 - $59.36 $364,809 - $668,987
11,270 Added 27.78%
51,845 $2.31 Million
Q4 2019

Feb 14, 2020
BUY
$32.22 - $50.07 $17,527 - $27,238
544 Added 1.36%
40,575 $1.95 Million
Q3 2019

Nov 14, 2019
SELL
$33.82 - $48.17 $303,703 - $432,566
-8,980 Reduced 18.32%
40,031 $1.35 Million
Q2 2019

Aug 14, 2019
SELL
$35.42 - $45.0 $1.77 Million - $2.25 Million
-49,915 Reduced 50.46%
49,011 $2.21 Million
Q1 2019

May 15, 2019
SELL
$28.09 - $39.49 $37,443 - $52,640
-1,333 Reduced 1.33%
98,926 $3.72 Million
Q4 2018

Feb 14, 2019
BUY
$29.83 - $46.51 $2.99 Million - $4.66 Million
100,259 New
100,259 $3.44 Million
Q3 2018

Nov 14, 2018
SELL
$33.9 - $47.77 $872,043 - $1.23 Million
-25,724 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$25.7 - $47.88 $8,018 - $14,938
312 Added 1.23%
25,724 $867,000
Q1 2018

May 15, 2018
SELL
$17.46 - $32.59 $10,196 - $19,032
-584 Reduced 2.25%
25,412 $688,000
Q4 2017

Feb 12, 2018
SELL
$15.14 - $20.89 $817,030 - $1.13 Million
-53,965 Reduced 67.49%
25,996 $434,000
Q3 2017

Nov 07, 2017
BUY
$16.81 - $21.61 $1.34 Million - $1.73 Million
79,961
79,961 $1.6 Million

Others Institutions Holding PTCT

# of Institutions
325
Shares Held
83.2M
Call Options Held
811K
Put Options Held
207K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $5.39B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email